|
The Pharmaceutical Industry: Innovation vs. Protection (2003)
This paper tackled the difficult issue of intellectual property rights within the pharmaceutical sector. Differentiating between downstream patents on final products and upstream patents on the components of these products, I analyzed the impact on innovation of two Congressional acts passed in the 1980s: the Bayh-Dole Act of 1980 and the Waxman-Hatch Act of 1984. The objective was to examine both positive and negative aspects of these acts in light of these two patent classifications. In addition, the paper examined the rationale behind the enactment of these acts. Ultimately, ideas were presented to tackle difficult issues in the form of policy recommendations striking a balance between innovation and protection in the industry.
-Rudey
|